For several years, prescription diabetes medicine Avandia has been at the center of a debate about whether the medication's heart attack risk was high enough to pull it from pharmacies. Now, nearly eight months after the FDA announced it would be introducing strict restrictions on its sale and use, the agency has finally gotten around to announcing the specifics of those restrictions.
More »
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
1 comment:
Why wait until November. We've been hearing bad news about this drug for more than a year now. To tell the truth, I thought it was already gone. It needs to be.
Post a Comment